NASDAQ

Iovance Biotherapeutics, Inc. (IOVA)

♥ 651 Thanks from members

Live price chart, market sentiment, and community perspectives for Iovance Biotherapeutics, Inc. (NASDAQ: IOVA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Iovance Biotherapeutics TeamLeadership: Friedrich von Bohlen (Chairman)Leadership: Adil Daud (Acting Leadership)Holder: Baker Bros. AdvisorsHolder: FMR LLCHolder: BlackRockAmtagvi (Lifileucel)TIL Cell Therapy Pipeline#IOVA#Iovance#TIL Therapy#Cancer Immunotherapy#Biotech